Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro

Zhao Sun, Zhe Liu, Jie Meng, Jinhong Duan, Sishen Xie, Xin Lu, Zhaohui Zhu, Chen Wang, Shuchang Chen, Haiyan Xu, Xian‐Da YangPLoS 2011 · DOI

Abstract

With the expansion of the potential applications of carbon nanotubes (CNT) in biomedical fields, the toxicity and biocompatibility of CNT have become issues of growing concern. Since the immune system often mediates tissue damage during pathogenesis, it is important to explore whether CNT can trigger cytotoxicity through affecting the immune functions. In the current study, we evaluated the influence of CNT on the cytotoxicity mediated by human lymphocytes in vitro. The results showed that while CNT at low concentrations (0.001 to 0.1 µg/ml) did not cause obvious cell death or apoptosis directly, it enhanced lymphocyte-mediated cytotoxicity against multiple human cell lines. In addition, CNT increased the secretion of IFN-γ and TNF-α by the lymphocytes. CNT also upregulated the NF-κB expression in lymphocytes, and the blockage of the NF-κB pathway reduced the lymphocyte-mediated cytotoxicity triggered by CNT. These results suggest that CNT at lower concentrations may prospectively initiate an indirect cytotoxicity through affecting the function of lymphocytes.

Introduction

As carbon nanotubes (CNTs) move closer to clinical applications in imaging and drug delivery, understanding their biocompatibility is paramount. Most toxicology research focuses on direct toxicity: the question of whether a nanoparticle physically damages or kills the cell it contacts.

However, the authors of this study argue that direct interaction is only part of the safety profile. The immune system often mediates tissue damage during disease states. This research investigates indirect toxicity: the potential for CNTs to interfere with immune signaling, causing white blood cells (lymphocytes) to become overactive and attack healthy or cancerous tissues indiscriminately.

Materials and Methods

The researchers utilized carboxylated multi-walled carbon nanotubes (MWCNTs), chemically modified for improved water solubility. The experimental design focused on the interaction between these nanotubes and human peripheral blood mononuclear cells (PBMCs), primarily lymphocytes isolated from healthy human volunteers.

The study evaluated effects across a diverse panel of human cell lines to ensure findings were not tissue-specific:

  • Cancer Lines: NCI-H23 and NCI-H838 (Lung), MCF-7 (Breast), and HepG2 (Liver).
  • Normal/Non-tumor Lines: L02 (Hepatocytes) and HSF (Skin fibroblasts).

Key methodologies included:

  • MTS Assays: To measure cell viability and growth inhibition.
  • Co-culture Models: Incubating "primed" lymphocytes with various target cell lines to measure killing efficacy.
  • ELISA: To quantify the secretion of pro-inflammatory cytokines, specifically Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α).
  • Western Blotting: To observe the nuclear translocation of NF-κB, a master regulator of the immune response.
  • Pathway Inhibition: Utilizing PDTC (an NF-κB inhibitor) to verify if blocking this specific pathway could mitigate CNT-induced lymphocyte aggression.

Results

The "Safe Dose" Paradox

At concentrations between 0.001 and 0.1 mg/ml, the CNTs did not cause significant direct cell death or apoptosis. In a standard toxicology screen, these doses might be labeled "safe." However, these same doses triggered significant indirect damage via immune modulation. Interestingly, while the lymphocytes became more cytotoxic, they did not divide or proliferate faster, suggesting the CNTs change the quality of the immune response rather than the quantity of immune cells.

Enhanced Cytotoxicity and Non-Specific Aggression

Lymphocytes treated with 0.01 mg/ml of CNTs showed a dramatic increase in killing ability. For the MCF-7 breast cancer line, the percentage of cells killed jumped from approximately 28% in the control group to over 50% in the CNT-treated group. Crucially, the "primed" lymphocytes did not just target cancer; they also increased their attack on healthy skin (HSF) and liver (L02) cells. This suggests that CNT exposure could potentially lead to systemic inflammation or autoimmune-like tissue damage.

NF-κB as the Regulatory "On Switch"

The study identifies the NF-κB signaling pathway as the primary mechanism for this effect. When CNTs enter the environment, they trigger this pathway in lymphocytes, leading to a significant up-regulation in the secretion of IFN-γ and TNF-α. This cytokine release facilitates the enhanced cell killing. When the researchers introduced the NF-κB inhibitor PDTC, the enhanced killing effect was significantly neutralized, confirming that the toxicity is a signaling-driven event rather than a mechanical one.

Discussion and Conclusion

This study highlights a critical aspect of nanoparticle safety: indirect, immune-mediated toxicity. Even at doses that appear benign in direct viability assays, CNTs can prime the immune system for non-specific aggression.

Several limitations must be noted. This study was conducted entirely in vitro. The complex regulatory environment of a living human body—where other immune cells might suppress or amplify this effect—remains to be explored. Furthermore, the study used carboxylated CNTs; since surface functionalization drastically changes how nanoparticles interact with proteins, other types of CNTs (e.g., aminated or raw) might produce different results. Future work is needed to determine if this immune priming is transient or if it could lead to chronic inflammatory conditions or long-term autoimmune issues in vivo.

Summary updated

Abstract

With the expansion of the potential applications of carbon nanotubes (CNT) in biomedical fields, the toxicity and biocompatibility of CNT have become issues of growing concern. Since the immune system often mediates tissue damage during pathogenesis, it is important to explore whether CNT can trigger cytotoxicity through affecting the immune functions. In the current study, we evaluated the influence of CNT on the cytotoxicity mediated by human lymphocytes in vitro. The results showed that while CNT at low concentrations (0.001 to 0.1 µg/ml) did not cause obvious cell death or apoptosis directly, it enhanced lymphocyte-mediated cytotoxicity against multiple human cell lines. In addition, CNT increased the secretion of IFN-γ and TNF-α by the lymphocytes. CNT also upregulated the NF-κB expression in lymphocytes, and the blockage of the NF-κB pathway reduced the lymphocyte-mediated cytotoxicity triggered by CNT. These results suggest that CNT at lower concentrations may prospectively initiate an indirect cytotoxicity through affecting the function of lymphocytes.
BibTeX
@inproceedings{sun2011carbon,
  author = {Zhao Sun and Zhe Liu and Jie Meng and Jie Meng and Jinhong Duan and Sishen Xie and Xin Lu and Zhaohui Zhu and Chen Wang and Shuchang Chen and Haiyan Xu and Xian‐Da Yang},
  title = {{Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro}},
  booktitle = {PLoS},
  year = {2011},
  doi = {10.1371/journal.pone.0021073},
}
Figure